Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)

Summary

This study will test the effects of an intervention to reduce substance use and related harms among people leaving rural jails or otherwise involved in the criminal justice system. This study will compare people in a health linkage intervention with people who will get overdose (OD) education. Everyone will take part in the baseline and follow-up surveys and receive OD education. Participants will be assigned to one of the two groups by chance based on when they are enrolled to the study and if their county is randomly assigned to an intervention or a comparison condition. By doing this study, the investigators hope to learn if providing linkage to health services along with HIV, hepatitis C virus (HCV), and overdose education to people leaving rural jails or otherwise involved in the criminal justice system will reduce substance use and related harms.

Conditions

• Substance Use
• HIV Infections
• HCV Infection
• Sexually Transmitted Infections (Not HIV or Hepatitis)
• Overdose, Drug
• Opioid Use

Interventions

BEHAVIORAL

Health Linkage

Research staff will: 1) help participants set goals and reduce their health risks by helping them to reflect on personal drug use, sexual relationships, and their consequences in the context of personal values and goals; 2) help link participants to services that they need and want; 3) offer participants the option of HIV and hepatitis C testing, provide the test result, and provide post-test counseling; and 4) provided participants nasal spray naloxone (Narcan) to carry with them in case they encounter someone who has an opioid overdose or in case they have an opioid overdose and a friend can use the naloxone to respond.

BEHAVIORAL

Overdose Education

Participants will complete a 10-minute overdose education training video on preventing, recognizing, and responding effectively to an opioid OD.

Sponsors & Collaborators

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• Appalachian Regional Commission

  collaborator OTHER

• Substance Abuse and Mental Health Services Administration (SAMHSA)

  collaborator FED

• Centers for Disease Control and Prevention

  collaborator FED

• Emory University

  collaborator OTHER

• April M Young

  lead OTHER

Principal Investigators

• April M Young, PhD, MPH · University of Kentucky

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2019-11-15

Primary Completion

2022-10-27

Completion

2022-10-27

Countries

• United States

Study Locations